REFERENCES
- Tandon B N, Acharya S K, Tandon A. Epidemiology of hepatitis B virus infection in India. Gut 1996; 38(S2)S56–S59
- Jha R, Kher V, Naik S R, Elhence V, Gupta A, Sharma RK. Mortality due to HBV in hemodialysis, Effect of vaccination. J Nephrol 1993; 6: 98–102
- Thomas P P, Kirubakaran M G, Jacob C K, et al. Hepatitis B infection in dialysis unit in South India. JAPI 1987; 35: 284–285
- Parfrey P S., Forbes R DS, Hutchinson T A, et al. The impact of renal transplantation on the course of Hepatitis B liver disease. Transplantation 1985; 39(6)610–615
- George G, John G T, Jacob C K, et al. Active immunization against Hepatitis B infection of a hemodialysis population – some problem. Natl Med J India 1984; 7: 115–116
- Stevens C E, Alter H J, Taylor P E, et al. The dialysis vaccine trial group Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med 1984; 31: 496–550
- Jilg W, Schmidt M, Weiner B, Kuttler T., Brass H., Bommer J., Muller R., Schulte B., Schwarzbeck A., Deinhardt F. Immunogenicity of recombinant Hepatitis B vaccine in dialysis patients. J Hepatol 1986; 3: 190–195
- Safary A. Hepatitis B vaccination – now and in the future. Hepatitis B in India – Problems and prevention, S K Sarin, Ak Singhal. CBS publishers, New Delhi 1996; 132–l51
- Buti M, Viladomiu L, Jardi R, Olmos O, Rodriguez J A, Bartolome J, Esteban R, Guardia J. Long term immunogenicity and efficacy of Hepatitis B vaccine in hemodialysis patients. Am J Nephrol 1992; 12: 144–l47
- Agarwal S K, Irshad M, Dash S C. Comparison of two schedules of hepatitis B vaccination in patients with mild, moderate and severe renal failure. JAPI 1999; 47(2)183–185
- Jacques J S, Patricia V N, Dierik LV. Treatment with recombinant human erythropoietin increases antibody titres after hepatitis B vaccination in dialysis patients. Kid Int 1991; 40: 121–128
- Meuer S C, Dumann H, Meyer zum Bueschenfelde K-H, Kohler H. Low dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis vaccination. Lancet 1989; 1: 15
- Hess G, Kreiter F, Kosters W, Deusch K. The effect of granulocyte-macrophage colony – stimulating factor (GM-CSF) on hepatitis B vaccination in hemodialysis patients. Journal of Viral Hepatitis 1996; 3: 149–153
- Rawer P, William W R, Breidenbach T H, et al. Seroconversion rate, hepatitis B vaccination, hemodialysis and zinc supplementation. Kid Int 1987; 32: 149–152
- Gibbons R A, Martinez O M, Garovoy M R. Altered monocyte function in uremia. Clin Immunol and Immunopath 1990; 56: 66–80
- Krishnamurthy G., Kher V., Naik S. Defective lymphoproliferative responses and interleukin 2 production in chronic renal failure patients. Indian J Med Res 1995; 102: 281–286
- Philip E T, Rong L, Edgar A M, John M K, Michel G, Thomas C J. Evaluation of tolerability and antibody response after recombinant human granulocyte macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine. Vaccine 1996; 14(13)1199–1204
- Carlson T, Struve J. Granulocyte macrophage colony stimulating factor as an adjuvant to persons not responding to hepatitis B vaccine. Infection 1997; 25: 129
- Malhotra K K, Saxena S, Mahajan M, Mishra P, Tiwary G, Hazarika A. Role of granulocyte macrophage colony stimulating factor in hepatitis B vaccination in hemodialysis patients – prospective trial. Ind J Neph 1999; 9(2)38–40
- Sudhakar K, Chandra Sekhar S, Rao M S, Ravichandran R. Effect of granulocyte macrophage colony stimulating factor on Hepatitis B vaccination in hemodialysis patients. JAPI 1999; 47: 602–604